IQVIA Holdings Inc. (LON:0JDM)
London · Delayed Price · Currency is GBP · Price in USD 207.07
+3.72 (1.83%)
At close: Oct 3, 2025
IQVIA Holdings Market Cap
IQVIA Holdings has a market cap or net worth of 26.07 billion as of October 3, 2025. Its market cap has decreased by -22.19% in one year.
Market Cap
26.07B
Enterprise Value
36.13B
Revenue
11.46B
Ranking
n/a
PE Ratio
28.87
Stock Price
207.07
Market Cap Chart
Since May 9, 2013, IQVIA Holdings's market cap has increased from 3.50B to 26.07B, an increase of 644.26%. That is a compound annual growth rate of 17.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 26.07B | -8.51% |
| Dec 31, 2024 | 28.49B | -14.06% |
| Dec 29, 2023 | 33.15B | 4.96% |
| Dec 30, 2022 | 31.58B | -20.65% |
| Dec 31, 2021 | 39.81B | 58.21% |
| Dec 31, 2020 | 25.16B | 11.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.12B |
| GSK plc | 66.29B |
| Haleon | 29.39B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 4.06B |
| HUTCHMED (China) | 2.03B |
| Genus | 1.64B |